Combination therapy of CK1 inhibitor SR3029 and Tip60 inhibitor MG149 had stronger inhibitory effects on β-catenin acetylation, transcription of Wnt target genes, and viability and proliferation of colon cancer cells (214). This evidence concerns the gene KAT5 and malignant colon neoplasm.